Effect of Fluconazole on the Pharmacokinetics of a Single Oral Dose of BI 425809 in Healthy Male Subjects (an Open-label, Two-period Fixed-sequence Design Study)
Latest Information Update: 25 Sep 2024
Price :
$35 *
At a glance
- Drugs Iclepertin (Primary) ; Fluconazole
- Indications Cognition disorders; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 11 Jan 2022 Status changed from active, no longer recruiting to completed.
- 22 Dec 2021 Planned End Date changed from 22 Dec 2021 to 28 Dec 2021.
- 22 Dec 2021 Planned primary completion date changed from 22 Dec 2021 to 28 Dec 2021.